Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regenerx Biopharmaceuticals Inc (RGN)  
$0.01 0.00 (0.00%) as of 4:30 Tue 10/17


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 106,883,000
Market Cap: 1.04(M)
Last Volume: 9,926 Avg Vol: 77,919
52 Week Range: $0.009725 - $0.047
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   RegeneRX Biopharmaceuticals is a biopharmaceutical company focused on the development of a therapeutic peptide, Thymosin beta 4 (Tss4), for tissue and organ protection, repair, and regeneration. Co. has formulated Tss4 into three product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 140
  Page 2 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sinaf S.a. 10% Owner   –       –       •   2017-10-13 4 A $0.00 $0 D/D 266,667 11,649,370     -
   Sinaf S.a. 10% Owner   –       –       •   2017-10-13 4 A $0.00 $0 D/D 1,671,296 11,382,703     -
   Goldstein Allan L Director   –       •      –    2017-01-31 4 GD $0.00 $0 D/D 125,000 681,743     -
   Finkelstein J J President and CEO   •       •      –    2016-12-30 5 GD $0.00 $0 D/D 100,000 1,388,188     -
   Finkelstein J J President and CEO   •       •      –    2016-12-01 5 $0.00 $0 D/D 210,550 1,488,188     -
   Finkelstein J J President and CEO   •       •      –    2016-12-01 5 A $0.00 $0 D/D 210,550 1,488,188     -
   Goldstein Allan L Director   –       •      –    2016-04-19 4 GD $0.00 $0 D/D 65,000 806,743     -
   Goldstein Allan L Director   –       •      –    2016-04-11 4 GD $0.00 $0 D/D 60,000 871,743     -
   Finkelstein J J President and CEO   •       •      –    2015-03-25 5 GD $0.00 $0 D/D 100,000 1,277,638     -
   Goldstein Allan L Director   –       •      –    2015-03-16 4 GD $0.00 $0 D/D 125,000 931,743     -
   Digital Aria 10% Owner   –       –       •   2014-08-29 4 OE $0.12 $1,000,000 D/D 8,333,333 19,583,333     -
   Goldstein Allan L Director   –       •      –    2014-06-02 4 GD $0.00 $0 D/D 250,103 1,056,743     -
   Digital Aria 10% Owner   –       –       •   2014-03-28 4 OE $0.12 $1,350,000 D/D 11,250,000 11,250,000     -
   Sinaf S.a. 10% Owner   –       –       •   2014-02-03 4 D $0.00 $0 D/D (64,575) 11,584,795     -
   Defiante Farmaceutica Lda 10% Owner   –       –       •   2011-01-05 4 B $0.27 $250,000 I/I 925,926 12,937,111 1.5     -
   Cavazza Claudio 10% Owner   –       –       •   2011-01-05 4 B $0.27 $600,000 I/I 2,222,222 12,937,111 1.5     -
   Cavazza Paolo 10% Owner   –       –       •   2011-01-05 4 B $0.27 $600,000 I/I 2,222,223 12,937,111 1.5     -
   Sinaf S.a. 10% Owner   –       –       •   2011-01-05 4 B $0.27 $350,000 D/D 1,296,297 9,711,407 2.45     -
   Goldstein Allan L Director   –       •      –    2010-12-07 5 GD $0.00 $0 D/D 20,000 1,536,846     -
   Goldstein Allan L Director   –       •      –    2010-09-15 5 GD $0.00 $0 D/D 30,000 1,556,846     -
   Sinaf S.a. 10% Owner   –       –       •   2010-06-29 3 IO $0.00 $0 D/D 0 8,415,110     -
   Lyons C Neil CFO & Treasurer   •       –      –    2010-06-11 4 B $0.28 $4,266 D/D 15,000 30,000 2.66     -
   Lyons C Neil CFO & Treasurer   •       –      –    2010-06-10 4 B $0.28 $1,422 D/D 5,000 15,000 2.66     -
   Cavazza Paolo 10% Owner   –       –       •   2010-05-21 4 B $0.00 $0 I/I 240,000 240,000 1.42     -
   Finkelstein J J President and CEO   •       •      –    2010-02-02 5 GD $0.00 $0 D/D 500 1,377,638     -
  140 Records found
  1  2  3  4  5  6   
  Page 2 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us